HPV vaccine

[toons]

Hi - My dd is due to receive the HPV vaccine this year. The posts on here all date back to 2016 and seem fairly anti. Does anyone have any more recent information regarding pros and cons? Thanks.

Can't help much with medical fact but I was part of the first group that went through the vaccine. Mostly me and my friends were fine, one girl wasn't 100% so went home early but was fine the next morning. However it seems to have been in vain in my case as I was sexually active before the vaccine (wasn't mentioned as an issue at the time) and received treatment for abnormal cells last year.

Hopefully someone that knows more will come along and be a bit more useful.

unreportedworldonline.wordpress.com/2018/04/22/hpv-vaccine-more-questions-than-answers/

vk.ovg.ox.ac.uk/hpv-vaccine

For balance. And, yes, I have given both my girls the vaccine. It is all about how you view risk. There is still a far higher risk of Cervical and other realted cancers, than there is risk of any adverse reaction to the vaccine, so I chose to vaccinate.

The number of girls reporting serious adverse events is very small in comparison to the number vaccinated, however is it acceptable for previously healthy teenagers to be collateral damage for the vaccination programme? The reports to the regulators of adverse events are far higher than for any other vaccination yet it is only given to girls. There is a very slow process for identifying problems with medicines/medical products - think Primodos, Valproate, mesh products. The onus is on campaign groups to make enough noise to be taken seriously and for anyone to investigate. There have been many safety studies done for the HPV vaccination, but no epidemiological studies (vaccinated vs unvaccinated) that would pick up POTS/CRPS/autonomic dysfunction.

Cancer Research UK quote the lifetime risk of Cervical Cancer in the UK as 0.76%.
Also bear in mind that there are factors that increase the risk of cervical cancer - smoking, long-term use of the contraceptive pill, poor diet, presence of other STDs. Most people will have an HPV infection at some point, but it is cleared from the body with no intervention.

"Risk is much higher for poor girls and women. For example, a study in England found that 80 percent of cervical cancer incidence occurred in the bottom two-fifths of the population, while none occurred in the top fifth and 7 percent in the second fifth (Shack et al. 2008). This stark inequality echoes the global picture and calls for a biosocial approach to researching and testing medicines (Bruni et al. 2016). The chances of higher-risk serotypes leading to cancer seem to depend on several cofactors, such as impaired immune responses, which vary inversely with income, lifestyle risks, sexual activity, and frequency of reinfection (Cancer Treatment Centers of America 2017). Thus, framing HPV vaccination as a simple solution deflects attention away from these inequalities of risk between affluent women who have good immune responses, access to routine screening and good care, and poorer women who do not."

From Institute of Advanced Study, Princeton University:

www.ias.edu/ideas/2017/light-cervical-cancer

www.google.ie/amp/s/www.irishtimes.com/news/health/number-of-deaths-in-cervical-screening-controversy-rises-to-18-1.3495763%3fmode=amp